Biohaven Pharmaceutical Holding Company Ltd.
Equities
BHVN
VGG111961055
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
42.16 USD | -4.25% | -21.18% | -72.23% |
Apr. 18 | Sector Update: Health Care Stocks Mixed Pre-Bell Thursday | MT |
Apr. 18 | Biohaven Prices $230 Million Public Share Offering | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-72.23% | 541M | |
-1.82% | 41.35B | |
+44.25% | 40.38B | |
+2.56% | 39.05B | |
-12.11% | 26.67B | |
+3.09% | 24.07B | |
-24.16% | 18.36B | |
+22.12% | 11.6B | |
-3.74% | 11.68B | |
+7.75% | 11.15B |
- Stock Market
- Equities
- BHVN Stock
- News Biohaven Pharmaceutical Holding Company Ltd.
- Wedbush Downgrades Biohaven Pharmaceutical to Neutral From Outperform, Noting Pfizer Deal 'On-Track,' Keeps $148.50 Price Target